Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels.
Varsavsky, Mariela; Reyes-García, Rebeca; García-Martín, Antonia; Rozas-Moreno, Pedro; González-Ramírez, Rocío; Rocío, González-Ramírez; Muñoz-Torres, Manuel.
J Bone Miner Metab
; 32(1): 65-70, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23640678
Does index tumor predominant location influence prognostic factors in radical prostatectomies?
Primary cryotherapy for localised or locally advanced prostate cancer.
Genetics and biology of prostate cancer.
Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk nonmetastatic prostate cancer: A systematic review and metaanalysis.
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.
Prostatic specific antigen for prostate cancer detection.
Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.
Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy.
Outcomes of treatment in men with prostate cancer at the cancer centre Bahamas.